Application no. and date | 19749864.5 (espacenet) (Federated) (European Patent Register), 20190617 | Patent/reg. no. and date | DK/EP 3807413, 20250521 | Publication date | 20210421 | Priority no. and date | US 201862686668 P, 20180618, US 201862740402 P, 20181002, US 201862752841 P, 20181030, US 201962823649 P, 20190325, US 201962860220 P, 20190611 | EP pub. no. and date |
EP 3807413 20210421 | Effective date | | Applicant/owner | Research Institute at Nationwide Children's Hospital, 700 Children's Drive, Room W172,
Columbus, Ohio 43205, US | Applicant ref. no. | 2014193 | Inventor | MENDELL, Jerry, R., 8176 Copperfield Drive
Columbus, OH 43235, US, RODINO-KLAPAC, Louise, 4912 Bixby Ridge Drive E.
Groveport, OH 43125, US | Representative | RWS Group, RWS Compass House
Vanwall Business Park, Vanwall Road
Maidenhead, Berkshire
SL6 4UB, GB | Opponent | | IPC Class | A61K 48/00 (2006.01) , C12N 15/86 (2006.01) | Title | ADENOASSOCIERET VIRUSVEKTORFREMFØRING AF MUSKELSPECIFIK MIKRODYSTROFIN TIL BEHANDLING AF MUSKELDYSTROFI | Int. application no. | US2019037489 | Int. publication no. | WO2019245973 | Related patent (certificate) | | Status | DK/EP patent | Pædiatrisk forlængelse | - | Udløbsdato for pædiatrisk forlængelse | - |
|